Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 26.
doi: 10.1111/1471-0528.18339. Online ahead of print.

Glycaemic Control in Women With Type 1 Diabetes and Preeclampsia Risk: A Nationwide Cohort Study

Affiliations

Glycaemic Control in Women With Type 1 Diabetes and Preeclampsia Risk: A Nationwide Cohort Study

Natalie Holowko et al. BJOG. .

Abstract

Objective: No large-scale studies exist investigating glycaemic control around conception and preeclampsia risk.

Design: Population-based nationwide cohort study using the National Diabetes Register and other health registers.

Setting: Sweden.

Population: Singleton pregnancies between 2003 and 2019 (N = 1 689 301); 4429 with type 1 diabetes (T1DM) and 1 684 872 without.

Methods: The main exposure was having a pre-gestational diagnosis of T1DM (first diagnosis anytime ≤ 91 days after conception and ≥ 1value of glycated haemoglobin (HbA1c) within ±90 days from conception). Peri-conceptional glycaemic control was categorised using the most recent HbA1c measurement (mmol/mol: < 48; 48-61; 62-75; ≥ 76). Unexposed were women without any diabetes diagnosis (≤ 91 days after conception).

Main outcome measures: Preeclampsia was defined using ICD codes and further categorised according to completed gestational weeks at delivery with preeclampsia diagnosis: early preterm preeclampsia (< 34 + 0), late preterm preeclampsia (34 + 0 to 36 + 6), or term preeclampsia (≥ 37 + 0).

Results: 16.8% of women with T1DM developed preeclampsia, compared to 2.9% of women without diabetes (adjusted RR [aRR] 4.7, 95% CI 4.4-5.0). Preeclampsia risk increased with peri-conceptional HbA1c, from 11.6% in women with HbA1c < 48 mmol/mol to 23.3% in women with HbA1c ≥ 76 mmol/mol. Compared to unexposed women, there was a dose-response relationship between HbA1c and preeclampsia in women with T1DM (HbA1c < 48 mmol/mol aRR 3.4 (2.9-4.0); HbA1c 48-61 mmol/mol aRR 4.6 (4.2-5.1); HbA1c 62-75 mmol/mol aRR 5.7 (5.0-6.5): HbA1c ≥ 76 mmol/mol aRR 6.3 (CI 5.3-7.7)). Compared to unexposed women, the aRR of term preeclampsia was 3.5 times higher (3.1-3.9) in women with T1DM, while the aRR was much higher for early preterm preeclampsia (aRR 7.2: 6.1-8.5) and late preterm preeclampsia (aRR 9.9: 8.8-11.1).

Conclusions: Women with T1DM had a higher risk of preeclampsia, which increased in a dose-response manner with poorer peri-conceptional glycaemic control.

Keywords: diabetes mellitus; hypertension; preeclampsia; pregnancy; pregnancy complications; pregnancy‐induced; type 1.

PubMed Disclaimer

References

    1. G. D. Ogle, F. Wang, A. Haynes, et al., “Global Type 1 Diabetes Prevalence, Incidence, and Mortality Estimates 2025: Results From the International Diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0,” Diabetes Research and Clinical Practice 225 (2025): 112277.
    1. G. A. Gregory, T. I. G. Robinson, S. E. Linklater, et al., “Global Incidence, Prevalence, and Mortality of Type 1 Diabetes in 2021 With Projection to 2040: A Modelling Study,” Lancet Diabetes and Endocrinology 10 (2022): 741–760.
    1. DIAMOND Project Group, “Incidence and Trends of Childhood Type 1 Diabetes Worldwide 1990–1999,” Diabetic Medicine 23 (2006): 857–866.
    1. P. Garner, “Type I Diabetes Mellitus and Pregnancy,” Lancet 346 (1995): 157–161.
    1. H. E. Fadl and D. Simmons, “Trends in Diabetes in Pregnancy in Sweden 1998‐2012,” BMJ Open Diabetes Research & Care 4 (2016): e000221.

LinkOut - more resources